
Rua Bioscience Investor Relations Material
Latest events

AGM 2024
Rua Bioscience

H2 2025
31 Aug, 2025

H1 2025
26 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rua Bioscience Limited
Access all reports
Rua Bioscience Limited is a pharmaceutical company focused on the cultivation, research, and production of medicinal cannabis products. The company operates in New Zealand, with a focus on developing cannabinoid-based therapies aimed at improving patient health and well-being. Rua Bioscience emphasizes sustainable cultivation practices and conducts research to support the development of safe and effective cannabis-based medicines. The company is headquartered in Gisborne, New Zealand, and its shares are listed on the NZX.
Key slides for Rua Bioscience Limited


AGM 2024
Rua Bioscience Limited


AGM 2024
Rua Bioscience Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
RUA
Country
🇳🇿 New Zealand